Nanovis is a rapidly growing nanotechnology surface company that focuses on improving spine, orthopedic, and dental surgical outcomes. Utilizing a broad portfolio of advanced nanotechnologies, the company has developed the nanoVIS Ti Surface Technology which has received FDA nanotechnology designation and clearance for use on commercially pure titanium and titanium alloy implants.
Founded in 2009 and headquartered in the United States, Nanovis operates within the biotechnology, health care, and manufacturing industries.
Notably, the company secured a significant $5.50M venture round investment on 28 August 2018. The investment was made by Elevate Ventures, Ellipsis Ventures, Commenda Capital, Purdue Foundry, and 1st Source Bank.
This injection of capital reflects the strong confidence of these investors in Nanovis and its potential within the nanotechnology and healthcare sectors.